The following experts on Parkinson’s disease are available to speak with reporters:
Co-director, Fixel Center for Neurological Diseases at UF Health; chair, department of neurology, UF College of Medicine; Adelaide Lackner professor of neurology; national medical director of the Parkinson’s Foundation
Cognitive, behavioral and mood effects of deep brain stimulation (DBS); non-motor basal ganglia brain features
Okun is co-director of the Fixel Center, a unique hub comprised of more than 45 interdisciplinary faculty members dedicated to care, outreach, education and research.
Chief of UF’s movement disorders division; assistant professor; Wright/Falls/Simmons professor in PSP/Atypical Parkinson’s
Understanding pathological mechanisms of Parkinson’s disease and related disorders, in particular the role of alpha-synuclein in cell toxicity and neurodegeneration; current studies use both cellular and preclinical models to study genes and molecules that may enhance or ameliorate alpha-synuclein toxicity.
Director, Parkinson’s Foundation Center of Excellence at UF; Barbara Padgett Dein Professor in Parkinson’s; president, Florida Society of Neurology
Improving quality of care in Parkinson’s disease; non-motor symptoms of Parkinson’s disease, including depression and psychosis; Duopa pump therapy for Parkinson’s disease; Tourette syndrome; non-motor comorbidities, pharmacologic and behavioral management; Botulinum toxin injection for movement disorders
Malaty is a primary investigator of a number of trials in Parkinson’s disease, Tourette syndrome, Huntington disease and dystonia.
Associate professor of neurology; director of clinical trials at the Fixel Center for Neurological Diseases
Clinical trials and neurotherapeutics in neurology, investigating novel deep brain stimulation surgical and programming techniques in movement disorders; understanding the neurophysiological brain changes observed in these conditions; and use of neuromodulation for the treatment of uncommon neurological diseases.
Assistant professor of neurology; director, Mangurian Clinical-Research Center for Lewy Body and Parkinson’s disease dementia
Cognitive impairment in Parkinson’s disease, Lewy Body Dementia and atypical Parkinsonisms; ways to assess and treat cognitive impairment and improve quality of life for patients with cognitive impairment and their caregivers/carepartners and families; and engaging patients directly to understand questions relevant to their daily lives
Associate professor of neurology, director of the Transcranial Magnetic Stimulation Laboratory and co-director for clinical trials in essential tremor, dystonia, Parkinson’s disease, Huntington’s disease and Tourette syndrome
Elucidating the mechanisms underlying deep brain stimulation surgery in DYT1 dystonia and understanding the pathophysiology of cervical dystonia.